LEADER 01474nam  2200397Ia 450 
001 9910698900903321
005 20090430154255.0
035   $a(CKB)5470000002396852
035   $a(OCoLC)319711756
035   $a(EXLCZ)995470000002396852
100   $a20090430d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and FDA staff$b[electronic resource] $eclass II special controls guidance document : automated blood cell separator device operating by centrifugal or filtration separation principle
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2007]
215   $ai, 6 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Apr. 30, 2009).
300   $a"November 2007".
320   $aIncludes bibliographical references (page 6).
517   $aGuidance for industry and FDA staff 
606   $aBlood cells
606   $aHemapheresis
606   $aSeparation (Technology)
615  0$aBlood cells.
615  0$aHemapheresis.
615  0$aSeparation (Technology)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698900903321
996   $aGuidance for industry and FDA staff$93451983
997   $aUNINA